Iotrolan - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for iotrolan and what is the scope of patent protection?
Iotrolan
is the generic ingredient in two branded drugs marketed by Bayer Hlthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for iotrolan
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 1,941 |
DailyMed Link: | iotrolan at DailyMed |
US Patents and Regulatory Information for iotrolan
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | OSMOVIST 240 | iotrolan | INJECTABLE;INTRATHECAL | 019580-002 | Dec 7, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Hlthcare | OSMOVIST 190 | iotrolan | INJECTABLE;INTRATHECAL | 019580-001 | Dec 7, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |